Areas of Research

Our research empowers communities, healthcare providers, and patients with knowledge that drives better liver health outcomes. We strive to reduce disease burden, promote early care, and improve quality of life through evidence-based action.

Viral Hepatitis Epidemiology

We study the patterns, causes, and impact of Hepatitis A, B, C, D, and E in diverse populations. Our research helps identify high-risk groups and informs strategies for prevention and control.

Hepatitis Elimination Research

We evaluate real-world public health interventions that support national viral hepatitis elimination goals. This research strengthens program delivery and identifies practical solutions to barriers in care.

Models of Hepatitis Care

We develop and assess innovative care models that improve the entire continuum of services—from screening to treatment. Our aim is to ensure accessible, efficient, and patient-centered hepatitis care.

Hepatitis Diagnostics & Treatment Capacity

We analyze healthcare system readiness for hepatitis testing and treatment. This includes evaluating laboratory capacity, treatment infrastructure, and workforce competencies.

MAFLD Epidemiology

We investigate the prevalence, risk factors, and health impact of Metabolic Associated Fatty Liver Disease (MAFLD). Our research supports early detection and targeted prevention strategies.

Liver Transplant Support Groups

We support initiatives that enhance the quality of life for individuals who have undergone liver transplantation. These groups provide emotional support, education, and long-term health guidance.

Community MAFLD Burden

We assess MAFLD prevalence within high-risk communities, particularly individuals with hypertension, diabetes, and high cholesterol. This helps guide targeted community-based interventions.

Metabolic Control in Hypertension & Diabetes

We measure how well people with hypertension and diabetes are managing their metabolic health. These insights help improve clinical practices and public health programs.

Linkage to Metabolic Care

We examine strategies to improve patient linkage from screening to treatment for metabolic conditions. Strengthening these pathways enhances early diagnosis and supports better long-term outcomes.

Cost-Effectiveness of Liver Diagnostics

We conduct pooled economic analyses to determine the most cost-effective diagnostic options for liver fibrosis. This evidence guides health policy and resource allocation.

Liver Health Implementation Research

We analyze health system processes to optimize liver-related services and interventions. This research improves program performance, scalability, and sustainability.

Early MAFLD Detection & Management

We focus on strengthening facility-level screening and management practices for MAFLD. This ensures timely identification and intervention to prevent disease progression.